Angle PLC announces Study using Parsortix in head and neck cancer
ANGLE plc STUDY USING PARSORTIX DEMONSTRATES IMPORTANCE OF BIOMARKER-INDEPENDENT CTC ISOLATION IN HEAD AND NECK CANCEREMT status of CTCs found to provide additional insight to tumour tissue biopsyPotential
Source: finanznachrichten.de